Floatz logo

16 assets in Brain Glioblastoma

Therapeutic assets addressing Brain Glioblastoma, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Tvi-Brain-1
Brain Glioblastoma
TVAX BiomedicalP2/3B (57)
Ruxolitinib
Brain Glioblastoma
Baptist Health South FloridaP2CCC (53)
Cis-Diamminedichloroplatinum Ii
Brain Glioblastoma
Zhongnan HospitalP1/2CC (47)
Antigen-Specific Igt Cells
Brain Glioblastoma
Shenzhen Geno-Immune Medical InstituteP1CC (43)
c134
Brain Glioblastoma
University of Alabama at BirminghamP1CC (43)
c5252
Brain Glioblastoma
ImmVira Pharma Co. LtdP1CC (43)
Chm-1101 Car-T Cells
Brain Glioblastoma
Chimeric TherapeuticsP1CC (43)
Definity
Brain Glioblastoma
Sunnybrook Health Sciences CentreP1CC (43)
Glix1
Brain Glioblastoma
Tetragon Biosciences LtdP1CC (43)
gpc3-car-t cells
Brain Glioblastoma
Baylor College of MedicineP1CC (43)
Photochemotherapy Using 3-Ethyl-3-Deacetyl-Bacteriopurpurin-18-N-Butylimide Methyl Ester
Brain Glioblastoma
Photolitec LLCP1CC (43)
AXUMIN
Brain Glioblastoma
Abramson Cancer Center at Penn MedicineEarly P1C (39)
Ketoconazole
Brain Glioblastoma
Milton S. Hershey Medical CenterEarly P1C (39)
Niraparib
Brain Glioblastoma
Nader SanaiEarly P1C (39)
Posaconazole
Brain Glioblastoma
Milton S. Hershey Medical CenterEarly P1C (39)